12213-1-AP
antibody from Proteintech Group
Targeting: MARCHF5
FLJ20445, MARCH-V, MARCH5, MITOL, RNF153
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12213-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12213-1-AP, RRID:AB_10638602
- Product name
- MARCH5 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated MARCH5 antibody (Cat. #12213-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, IP, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Triflupromazine and tranylcypromine alleviate primary cisplatin resistance in lung adenocarcinoma by promoting LDHA-mediated AMBRA1 ubiquitination.
MARCH5 ameliorates aortic valve calcification via RACGAP1-DRP1 associated mitochondrial quality control.
Uric acid promotes aortic valve calcification via mediating valve interstitial cell osteogenic differentiation and endothelial dysfunction.
Targeting the WSB2-NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors.
FABP4 deactivates NF-κB-IL1α pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression.
Wang Q, Zhang Y, Zhang Y, Zhai Y, Zhou X, Qin Y, Ding M, Tian Y, Zhang Z, Zhang P, Xu F
Biochemical pharmacology 2025 Sep;239:117073
Biochemical pharmacology 2025 Sep;239:117073
MARCH5 ameliorates aortic valve calcification via RACGAP1-DRP1 associated mitochondrial quality control.
Zhang J, Zhang Y, Lei W, Zhou J, Xu Y, Hao Z, Liao Y, Huang F, Chen M
Biochimica et biophysica acta. Molecular cell research 2025 Mar;1872(3):119911
Biochimica et biophysica acta. Molecular cell research 2025 Mar;1872(3):119911
Uric acid promotes aortic valve calcification via mediating valve interstitial cell osteogenic differentiation and endothelial dysfunction.
Zhang J, Lei W, Zhou J, Zhang Y, Huang F, Chen M
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2025 Mar 31;39(6):e70437
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2025 Mar 31;39(6):e70437
Targeting the WSB2-NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors.
Jiao D, Chang K, Jin J, Chen Y, Ren M, Zhang Y, Gao K, Xu Y, Wang L, Wang C
eLife 2025 Jul 23;13
eLife 2025 Jul 23;13
FABP4 deactivates NF-κB-IL1α pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression.
Miao L, Zhuo Z, Tang J, Huang X, Liu J, Wang HY, Xia H, He J
Clinical and translational medicine 2021 Apr;11(4):e395
Clinical and translational medicine 2021 Apr;11(4):e395
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 12213-1-AP(MARCH5 antibody) at dilution of 1:400
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The MARCH5 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human MARCH5. This antibody recognizes human antigen. The MARCH5 antibody has been validated for the following applications: ELISA, WB, IHC analysis.